Cargando…
CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
Clustered regularly interspaced short palindromic repeats (CRISPR) is a third-generation genome editing method that has revolutionized the world with its high throughput results. It has been used in the treatment of various biological diseases and infections. Various bacteria and other prokaryotes s...
Autores principales: | Tiwari, Prashant Kumar, Ko, Tin-Hsien, Dubey, Rajni, Chouhan, Mandeep, Tsai, Lung-Wen, Singh, Himanshu Narayan, Chaubey, Kundan Kumar, Dayal, Deen, Chiang, Chih-Wei, Kumar, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352522/ https://www.ncbi.nlm.nih.gov/pubmed/37469704 http://dx.doi.org/10.3389/fmolb.2023.1214489 |
Ejemplares similares
-
Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022) -
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope
por: Karn, Vamika, et al.
Publicado: (2022) -
A Small RNA Is Linking CRISPR–Cas and Zinc Transport
por: Märkle, Pascal, et al.
Publicado: (2021) -
Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
por: Li, Xiaoping, et al.
Publicado: (2023) -
The Influence of Copy-Number of Targeted Extrachromosomal Genetic Elements on the Outcome of CRISPR-Cas Defense
por: Severinov, Konstantin, et al.
Publicado: (2016)